InvestorsHub Logo
icon url

investingdog

06/07/13 7:56 PM

#126668 RE: biopharm #126663

<<Strategic reason #1) In order to "continue" buying cheaper future call options.... so the money they lose selling the shares they could gain on the call option>>


The total call volume for June expiration is barely 500k shares. That is peanuts for heavy hitters, it is only retail trading those options. Besides, pros rarely buy options, they write them - that is where the money is but not right now in PPHM case, not enough volume. Most options expire worthless.